Stonerise Parkersburg | |
1600 27th Street, Parkersburg, West Virginia 26101 | |
(304) 485-6476 | |
Name | Stonerise Parkersburg |
---|---|
Location | 1600 27th Street, Parkersburg, West Virginia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 164 |
Occupancy Rate | 52.2% |
Medicare ID (CCN) | 515159 |
Legal Business Name | Parkersburg Acquisition Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1518954908 |
Organization Name | EAGLE POINTE, INC |
Address | 1600 27th St, Parkersburg, WV 26101 |
Phone Number | 304-485-6476 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University of Florida.
Harmful effects of medication bring an estimated 4.5 million patients to doctors' offices and emergency rooms yearly, according to a new study, and people who take multiple medications are particularly vulnerable to unpleasant or dangerous side effects, allergic reactions and toxicity.
Historic five-year results from the world's largest clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) were presented last week at the Leipzig Interventional Course, in Germany. The data confirm long-term patency for patients treated with Zilver® PTX®.
› Verified 5 days ago
NPI Number | 1730497892 |
Organization Name | 1600 27TH STREET OPERATIONS LLC |
Doing Business As | EAGLE POINTE |
Address | 1600 27th St, Parkersburg, WV 26101 |
Phone Number | 610-925-4436 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University of Florida.
Harmful effects of medication bring an estimated 4.5 million patients to doctors' offices and emergency rooms yearly, according to a new study, and people who take multiple medications are particularly vulnerable to unpleasant or dangerous side effects, allergic reactions and toxicity.
Historic five-year results from the world's largest clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) were presented last week at the Leipzig Interventional Course, in Germany. The data confirm long-term patency for patients treated with Zilver® PTX®.
› Verified 5 days ago
NPI Number | 1992444145 |
Organization Name | 27TH STREET LEASING CO., LLC |
Doing Business As | STONERISE PARKERSBURG |
Address | 1600 27th St, Parkersburg, WV 26101 |
Phone Number | 304-485-6476 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University of Florida.
Harmful effects of medication bring an estimated 4.5 million patients to doctors' offices and emergency rooms yearly, according to a new study, and people who take multiple medications are particularly vulnerable to unpleasant or dangerous side effects, allergic reactions and toxicity.
Historic five-year results from the world's largest clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) were presented last week at the Leipzig Interventional Course, in Germany. The data confirm long-term patency for patients treated with Zilver® PTX®.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University of Florida.
Harmful effects of medication bring an estimated 4.5 million patients to doctors' offices and emergency rooms yearly, according to a new study, and people who take multiple medications are particularly vulnerable to unpleasant or dangerous side effects, allergic reactions and toxicity.
Historic five-year results from the world's largest clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) were presented last week at the Leipzig Interventional Course, in Germany. The data confirm long-term patency for patients treated with Zilver® PTX®.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $80399 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.76 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.01 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.32 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.63 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.92 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.29 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 5.21 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 6.21 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.86 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.2 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 30.71 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.93 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 3.23 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.59 | 95.98 |
Percentage of short-stay residents who made improvements in function | 63.18 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.2 | 82.93 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University of Florida.
Harmful effects of medication bring an estimated 4.5 million patients to doctors' offices and emergency rooms yearly, according to a new study, and people who take multiple medications are particularly vulnerable to unpleasant or dangerous side effects, allergic reactions and toxicity.
Historic five-year results from the world's largest clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) were presented last week at the Leipzig Interventional Course, in Germany. The data confirm long-term patency for patients treated with Zilver® PTX®.
› Verified 5 days ago
Worthington Healthcare Center Location: 2675 36th Street, Parkersburg, West Virginia 26104 Phone: (304) 485-7447 | |
Stonerise Parkersburg Location: 1600 27th Street, Parkersburg, West Virginia 26101 Phone: (304) 485-6476 | |
Ohio Valley Health Care Location: 222 Nicolette Road, Parkersburg, West Virginia 26104 Phone: (304) 485-5137 |